相关实验视频

Updated: Apr 14, 2026

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

M2 巨细胞衍生小细胞外囊泡改善热和椎间盘退化

Kaihui Zhang¹, Lilong Du¹, Zhenhua Li¹

¹Department of Minimally Invasive Spine Surgery, Tianjin Hospital, Tianjin University, Tianjin 300211, China.

Biomaterials research

|July 2, 2024

概括

来自M2巨细胞 (M2-sEVs) 的小型细胞外囊泡显示出通过抑制细胞死亡和促进细胞迁移来促进椎间盘再生的前景. 一种水凝输送系统在变性模型中增强了它们的治疗潜力.

科学领域:

生物医学工程生物医学工程
再生医学是一种再生医学.
细胞生物学细胞生物学

背景情况:

椎间盘退化 (IDD) 是一个重要的临床挑战,其再生能力有限.
目前用于IDD的治疗策略往往不令人满意,需要新的方法.
来自M2巨细胞 (M2-sEVs) 的小细胞外囊泡 (sEVs) 已显示出抗炎性质和组织修复的潜力.

研究的目的:

研究M2-sEVs在椎间盘再生中的治疗潜力和潜在机制.
探索M2-sEVs在调节核细胞 (NPC) 行为和热的作用.
为M2-sEVs开发持续释放输送系统,以提高其在IDD模型中的有效性.

主要方法:

在实验室中对用M2-sEVs治疗的核细胞 (NPC) 进行了研究.
生物信息分析和微RNA (miR) 表达的实验验证,特别是miR-221-3p.
用于控制M2-sEVs释放的脱细胞化细胞外基质水凝 (dECM) 的制造.
在脊椎间盘退化 (IDD) 动物模型中对dECM/M2-sEVs的体内评估.

主要成果:

M2-sEVs抑制了NPC热,增强了细胞活力,并在体外促进了NPC迁移.
确定miR-221-3p是M2-sEVs转移的关键分子,抑制PTEN和NLRP3的表达.
该dECM/M2-sEVs水凝证明了生物相容性和受控释放,有效地延迟了体内IDD的进展.

结论:

M2-sEVs代表了一种有前途的无细胞治疗策略,用于椎间盘再生.
这种机制涉及M2-sEVs介导的miR-221-3p的转移,抑制NPCs中的烧亡途径.
一个dECM-水凝输送系统增强了M2-sEVs治疗IDD的治疗疗效.

更多相关视频

Optical Sectioning and Visualization of the Intervertebral Disc from Embryonic Development to Degeneration

Optical Sectioning and Visualization of the Intervertebral Disc from Embryonic Development to Degeneration

Published on: July 8, 2021

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits

Published on: July 21, 2023

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...